Harvard Bioscience HBIO Earnings Call Transcripts

NASDAQ HBIO
$9.26 +0.17 (+1.87%)
At close: Nov 10, 2026 · 4:00 PM EST
3 earnings calls on file for Harvard Bioscience, from Mar 12, 2026 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Harvard Bioscience Q2 2026 Earnings Call

Aug 11, 2026 2,955 words · 13 min read
  • Taylor KrafchikSenior Vice President at Ellipsis
  • John DukePresident and Chief Executive Officer
  • Mark FrostChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Harvard Bioscience Earnings Call Transcripts

Calls3
LatestAug 11, 2026
SinceMar 12, 2026

Fiscal 2026

All 3 Harvard Bioscience transcripts Register to get access to Harvard Bioscience’s earnings call transcripts.